Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gennum Corporation was a prominent Canadian semiconductor company that specialized in high-performance analog and mixed-signal integrated circuits. While widely recognized for its contributions to the video broadcast industry, the company played a critical role in the healthcare sector through its Hearing Instrument division, where it was a global leader in signal processing technology for hearing aids. Its advanced chips enabled low-power, high-fidelity audio processing, which became a standard for modern hearing prosthetics. The company was acquired by Semtech Corporation in 2012 for approximately $494 million, integrating its specialized audio and video technologies into Semtech's broader portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gennum.